Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects-Reference-Cited by-同舟云学术

Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects

Published:2019-09-25 Issue:4 Volume:9 Page:505-513
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Li Xiaojiao¹,Liu Jingrui¹,Sheng Changcheng²,Chen Hong¹,Cui Dongyang³,Chen Guiling¹,Zhang Hong¹,Zhu Xiaoxue¹,Wu Min¹,Li Cuiyun¹,Shen Zhenwei⁴,Guo Yingjie⁵,Ding Yanhua¹,Jiao Zheng²

Affiliation:

1. Phase I Clinical Trial UnitFirst Hospital, Jilin University Jilin China

2. Department of PharmacyHuashan Hospital, Fudan University Shanghai China

3. Jiangsu Hengrui Medicine Co Ltd Jiangsu China

4. First Hospital and Institute of Immunology, First Hospital, Jilin University Jilin China

5. School of Life SciencesJilin University Jilin China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.735

Reference22 articles.

1. Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension

2. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study

3. A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

4. Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

5. Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed‐Dose Combination in Healthy Adults